Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20818855 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed HD10 for Early Stages
Condition: Hodgkin´s Lymphoma
Interventions: Drug: Adriamycin;   Drug: Bleomycin;   Drug: Vinblastine;   Drug: DTIC;   Radiation: 30 Gy IF-RT;   Radiation: 20 Gy IF-RT

Indicates status has not been verified in more than two years